This ‘living drug’ could change the course of autoimmune disease
If given the green light by the FDA, a CAR T cell therapy from Kyverna Therapeutics would be the first approved treatment for stiff person syndrome.
We haven't written up this one. Science News has the full story — the link below goes straight to it.